Saudi Arabia’s Public Investment Fund, the Qatar Investment Authority, and Abu Dhabi’s L’imad Holding Co are all aboard, per the WSJ.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Soleno Therapeutics’s Vykat XR is the first drug to be approved for treating the insatiable hunger caused by Prader-Willi Syndrome.
By 2030, as much as one-third of data centers will be powered entirely by on-site and off-grid power generation, according to Bloom Energy.
Nestlé, meanwhile, is looking to offload 50% of its water business in a shift away from capital-intensive, lower-growth segments.
Average jet fuel prices have outpaced the rise in oil prices, soaring about 100% in the month since the start of the Iran war.
NASA is teaming up with a host of private companies to build a lunar economy ready to welcome humans to the moon’s inhospitable surface.
The oil price shock caused by the Iran war has turbocharged BP shares, pushing them up roughly 33% so far this year.
The e-bike industry has spent the last year in a Chapter 11 shredder, but a new “War Economy” at the pump is changing the math.
Tuesday’s deal would see Unliver “sharpening” into a $45 billion “pure play” in global beauty, wellness, and personal and home care.
During its third-quarter earnings call tomorrow, executives will continue to pitch shareholders on the company’s egg-breaking transformation.
Clear has gained a cult following of travelers who like to show up for flights five minutes before boarding.
Nike is trying to make a comeback under CEO Elliott Hill, who started in 2024 at a time when the shoe company seemed to veer off course.
Talk about automation is swamping American industries, but are the companies tossing around tech-savvy buzzwords overstating robotic reality?
Midwest farmers told the Des Moines Register that they’re already being quoted fertilizer prices that are up 40% from the fall.
The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.
The space agency also said Tuesday that it is planning to build a new nuclear-powered robotic spacecraft to launch to Mars by 2028.